在儿科低度质瘤中MEK抑制的作用
Shehryar R Sheikh1,2, Laura J Klesse3, Ross Mangum4
1Department of Neurosurgery, Cleveland Clinic, Cleveland, OH, United States.
Frontiers in oncology
|January 6, 2025
概括
MEK 抑制剂为儿科低度质瘤 (pLGGs) 提供了一个有前途的新疗法,有可能改善无法切除瘤的儿童的治疗结果,并减少化疗的副作用.
科学领域:
- 儿科瘤学 儿科瘤学
- 神经瘤学神经瘤学
- 分子向疗法分子向疗法
背景情况:
- 儿科低度质瘤 (pLGGs) 是最常见的儿科脑瘤.
- 目前的治疗方法,如化疗,可以导致显著的长期副作用和瘤复发在不可切除的情况下.
研究的目的:
- 探索MEK抑制剂在管理pLGGs中的新兴作用.
- 审查pLGG治疗中MEK抑制剂的分子理由,临床证据和挑战.
主要方法:
- 关于pLGG的MEK抑制剂的临床前和临床研究的文献综述.
- 在pLGG中,MEK抑制剂准的分子通路的分析.
- 对MEK抑制剂在儿科患者中有效性和安全性的现有证据的评估.
主要成果:
- MEK 抑制剂向在pLGG中失调的关键信号通路.
- 临床数据表明,MEK抑制剂在特定的pLGG亚型中具有潜在的疗效.
- 挑战包括确定最佳患者群体和管理潜在的毒性.
结论:
- MEK 抑制剂代表了PLGGs的一个有前途的治疗策略,为传统化疗提供了替代方案.
- 需要进一步的研究来完善治疗方案,并应对广泛临床采用的挑战.
更多相关视频
12:52Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
09:43Transplantation of Zebrafish Pediatric Brain Tumors into Immune-competent Hosts for Long-term Study of Tumor Cell Behavior and Drug Response
Published on: May 17, 2017
相关概念视频
Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
